Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000216333 | SCV000277403 | pathogenic | Hereditary cancer-predisposing syndrome | 2015-07-23 | criteria provided, single submitter | clinical testing | The c.2156delC pathogenic mutation, located in coding exon 5 of the PALB2 gene, results from a deletion of one nucleotide at position 2156, causing a translational frameshift with a predicted alternate stop codon. Since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). |
Counsyl | RCV000663079 | SCV000786156 | likely pathogenic | Familial cancer of breast | 2018-03-12 | criteria provided, single submitter | clinical testing |